Table 2.
Selected* recommendations for interpreting serum total 25-hydroxyvitamin D concentrations by type of committee, year of publication and consistency with UK DRV 1991, IOM2011 or Endocrine Society 2012 recommendations
| Type of committee | Year of publication | Consistent with |
|---|---|---|
| Governmental | ||
| UK DRV(17) | 1991 | UK DRV 1991 |
| US IOM(33) | 1997 | UK DRV 1991 |
| UK COMA(19) | 1998 | UK DRV 1991 |
| The Netherlands(40) | 2012 | UK DRV 1991† |
| UK SACN(21) | 2016 | UK DRV 1991 |
| US IOM(35) | 2011 | US IOM 2011 |
| NORDIC(37) | 2012 | US IOM 2011 |
| Swiss Federal Commission for Nutrition(38) | 2012 | US IOM 2011 |
| European Food Safety Authority(39) | 2016 | US IOM 2011 |
| Non-governmental/medical societies | ||
| Lawson Wilkins Pediatric Endocrine Society(41) | 2008 | US IOM 2011 |
| German, Austrian, & Swiss Nutrition Societies (DACH)(42) | 2012 | US IOM 2011 |
| Australia/New Zealand(43,44) | 2012/2013 | US IOM 2011 |
| British Paediatric(45) | 2012 | US IOM 2011 |
| French Society of Pediatrics(46) | 2012 | US IOM 2011 |
| Spanish Association of Pediatrics(47) | 2012 | US IOM 2011 |
| European Society for Paediatric Gastroenterology, Hepatology and Nutrition(48) | 2013 | US IOM 2011 |
| American Academy of Pediatrics(49,50) | 2008, 2014 | US IOM 2011 |
| Global Consensus Recommendations(51) | 2016 | US IOM 2011 |
| Canadian Paediatric Society(53) | 2007 | Endocrine Society |
| International Osteoporosis Foundation(54) | 2010 | Endocrine Society |
| Scientific Advisory Council of Osteoporosis Canada(55) | ||
| Endocrine Society(52) | 2011 | Endocrine Society |
| Central Europe(56) | 2013 | Endocrine Society |
| Society for Adolescent Health and Medicine(57) | 2013 | Endocrine Society |
| American Geriatrics Society Workshop(58) | 2014 | Endocrine Society |
| National Osteoporosis Foundation(59) | 2014 | Endocrine Society |
| Vitamin D Council(60) | 2015 | Endocrine Society |
| United Arab Emirates(61) | 2016 | Endocrine Society |
| Japanese Medical Societies(62) † | 2017 | Endocrine Society‡ |
| Italian Pediatric Society(63) | 2018 | Endocrine Society |
*
Adapted, in part, from Bouillon(1) and Saggese et al.(63).
†
Expert panel supported by the research programme of intractable diseases; Ministry of Health, Labour and Welfare, Japan; the Japanese Society for Bone and Mineral Research; and the Japan Endocrine Society. It is not clear if this was a ‘governmental’ set of guidelines.
‡
Recommendations for: ages 0–70: serum 25(OH)D level >12 ng/ml (30 nmol/l); and age >70: risk of bone fractures and serum 25(OH)D > 20 ng/ml (50 nmol/l).